N3 alkylated benzimidazole derivatives as mek inhibitors

Details for Australian Patent Application No. 2003218157 (hide)

Owner Array Biopharma, Inc

Inventors Marlow, Allison, L.; Hurley, Brian, T.; Wallace, Eli, M.; Lyssikatos, Joseph, P.

Agent Watermark

Pub. Number AU-B-2003218157

PCT Number PCT/US03/07864

PCT Pub. Number WO2003/077914

Priority 60/364,007 13.03.02 US

Filing date 13 March 2003

Wipo publication date 29 September 2003

Acceptance publication date 9 July 2009

International Classifications

C07D 235/08 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 31/4184 (2006.01)

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 Antineoplastic agents

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/364,007 13.03.02 US

6 November 2003 Application Open to Public Inspection

  Published as AU-B-2003218157

9 July 2009 Application Accepted

  Published as AU-B-2003218157

5 November 2009 Standard Patent Sealed

21 July 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 17 Jun 2011. Address for service in Australia - Watermark Patent and Trade Marks Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122 2005

24 November 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 17 Jun 2011 2004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003218158-MULTIPLE IMAGING SYSTEM AND METHOD FOR DESIGNING SAME

2003218156-CELL DIVISION AND PROLIFERATION PREFERRED REGULATORY ELEMENTS AND USES THEREOF